Dec 08, 2014
|
Ito, M., Hayashi, K., Adachi, E., Minamisawa, T., Homma, S., Koido, S., Shiba, K. Combinatorial contextualization of peptidic epitopes for enhanced cellular immunity. PLoS One, 9, e110425 (2014)
|
Dec 05, 2014
|
Isoyama, S., Kajiwara, G., Tamaki, N., Okamura, M., Yoshimi, H., Nakamura, N., Kawamura, K., Nishimura, Y., Namatame, N., Yamori, T., Dan, S. Basal expression of IGF-1 receptor determines intrinsic resistance of cancer cells to a PI3K inhibitor ZSTK474. Cancer Sci, 106, 171-178 (2015)
|
Nov 21, 2014
|
Uehara, Y., Inoue, M., Fukuda, K., Yamakoshi, H., Hosoi, Y., Kanda, H., Oshima, M., Iwabuchi, Y., Shibata, H. Inhibition of β-catenin and STAT3 with a curcumin analog suppresses gastric carcinogenesis in vivo. Gastric cancer, in press (2014)
|
Nov 21, 2014
|
Sekiguchi, K., Ogawa, Y., Sanuki, N., Arahira, S., Ogo, E., Yoshimura, M., Yamauchi, C., Oguchi, M., Ohsumi, S., Mukai, H. The Japanese Breast Cancer Society clinical practice guideline for radiotherapy of breast cancer. Breast Cancer, in press (2014)
|
Nov 21, 2014
|
Honma, N., Horii, R., Iwase, T., Saji, S., Younes, M., Ito, Y., Akiyama, F. Proportion of estrogen or progesterone receptor expressing cells in breast cancers and response to endocrine therapy. Breast, in press (2014)
|
Nov 21, 2014
|
Yamaguchi, J., Nagayama, S., Chino, A., Sakata, A., Yamamoto, N., Sato, Y., Ashihara, Y., Kita, M., Nomura, S., Ishikawa, Y., Igarashi, M., Ueno, M., Arai, M. Identification of coding exon 3 duplication in the BMPR1A gene in a patient with juvenile polyposis syndrome. Jpn J Clin Oncol, in press (2014)
|
Nov 21, 2014
|
Horii, R., Matsuura, M., Dan, S., Ushijima, M., Uehiro, N., Ogiya, A., Honma, N., Ito, Y., Iwase, T., Yamori, T., Akiyama, F. Extensive analysis of signaling pathway molecules in breast cancer: association with clinicoapthological characteristics. Int J Clin Oncol, in press (2014)
|
Nov 21, 2014
|
Nakagawa, T., Horii, R., Ito, Y., Iwase, T., Akiyama, F. Development of an easy method to test for HER2 in breast cancer using dual-color in situ hybridization. Breast Cancer, in press (2014)
|
Nov 21, 2014
|
Katayama, R., Friboulet, L., Koike, S., Lockerman, E.L., Khan, T.M., Gainor, J.F., Iafrate, A.J., Takeuchi, K., Taiji, M., Okuno, Y., Fujita, N., Engelman, J.A., Shaw, A.T. Two novel ALK mutations mediate acquired resistance to the next-generation AKL inhibitor alectinib. Clin Cancer Res, in press (2014)
|
Nov 21, 2014
|
Kim, S.J., Masuda, N., Tsukamoto, F., Inaji, H., Akiyama, F., Sonoo, H., Kurebayashi, J., Yoshidome, K., Tsujimoto, M., Takei, H., Masuda, S., Nakamura, S., Noguchi, S. The cell cycle profiling-risk score based on CDK1 and 2 predicts early recurrence in node-negative, hormone receptor-positive breast cancer treated with endocrine therapy. Cancer Lett, 355, 217-223 (2014)
|
Nov 21, 2014
|
Rempel, R.E., Jiang, X., Fullerton, P., Tan, T.Z., Ye, J., Lau, J.A., Mori, S., Chi, J.T., Nevins, J.R., Friedman, D.R. Utilization of the Eμ-Myc mouse to model heterogeneity of therapeutic response. Mol Cancer Ther, 13, 3219-3229 (2014)
|
Nov 21, 2014
|
Miow, Q.H., Tan, T.Z., Ye, J., Lau, J.A., Yokomizo, T., Thiery, J.P., Mori, S. Epithelial-mesenchymal status renders differential responses to cisplatin in ovarian cancer. Oncogene, 34, 1899-1907 (2014)
|
Nov 21, 2014
|
Nakano, K., Inagaki, L., Tomomatsu, J., Motoi, N., Gokita, T., Ae, K., Tanizawa, T., Shimoji, T., Matsumoto, S., Takahashi, S. Incidence of pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment. Clin Oncol, 26, 357 (2014)
|
Nov 21, 2014
|
Gorai, A., Sakao, Y., Kuroda, H., Uehara, H., Mun, M., Ishikawa, Y., Nakagawa, K., Masuda, M., Okumura, S. The clinicopathological features associated with skip N2 metastases in patients with clinical stage IA non-small-cell lung cancer. Eur J Cardiothorac Surg, 47, 653-658 (2015)
|
Nov 21, 2014
|
Horii, R., Honma, N., Ogiya, A., Kozuka, Y., Fukuda, T., Yoshida, M., Ohsumi, S., Mukai, H. The Japanese Breast Cancer Society Clinical Practice Guideline for pathological diagnosis of breast cancer. Breast Cancer, 22, 59-65 (2015)
|
Oct 30, 2014
|
Katayama, R., Kobayashi, Y., Friboulet, L., Lockerman, E.L., Koike, S., Shaw, A.T., Engelman, J.A., Fujita, N. Cabozantinib overcomes crizotinib resistance in ROS1 fusion positive
cancer. Clin Cancer Res, in press (2014)
|
Oct 29, 2014
|
Kodama, T., Motoi, N., Ninomiya, H., Sakamoto, H., Kitada, K., Tsukaguchi, T., Satoh, Y., Nomura, K., Nagano, H., Ishii, N., Terui, Y., Hatake, K., Ishikawa, Y. A novel mechanism of EML4-ALK rearrangement mediated by chromothripsis in a patient-derived cell Ll. J Thorac Oncol, in press (2014)
|
Oct 29, 2014
|
Lee, S.E., Kang, S.Y., Takeuchi, K., Ko, Y.H. Identification of RANBP2-ALK fusion in ALK positive diffuse large B-cell lymphoma. Hematol Oncol, in press (2014)
|
Oct 29, 2014
|
Nakada, T., Okumura, S., Kuroda, H., Uehara, H., Mun, M., Takeuchi, K., Nakagawa, K. Imaging characteristics in ALK fusion-positive lung adenocarcinomas by using HRCT. Ann Thorac Cardiovasc Surg, in press (2014)
|
Oct 29, 2014
|
Nitta, H., Terui, Y., Yokoyama, M., Mishima, Y., Nishimura, N., Ueda, K., Kusano, Y., Tsuyama, N., Takeuchi, K., Kanda, Y., Hatake, K. Absolute peripheral monocyte count at diagnosis predicts central nervous system relapse in diffuse large B-cell lymphoma. Haematologica, in press (2014)
|
Oct 29, 2014
|
Sakurai, H., Sugimoto, K.J., Shimada, A., Imai, H., Wakabayashi, M., Sekiguchi, Y., Ota, Y., Izutsu, K., Takeuchi, K., Komatsu, N., Noguchi, M. Primary CNS CCND1/MYC-positive double-hit B-cell lymphoma: A case report and review of the literature. J Clin Oncol, in press (2014)
|
Oct 29, 2014
|
Tomita, N., Kodama, F., Tsuyama, N., Sakata, S., Takeuchi, K., Ishibashi, D., Koyama, S., Ishii, Y., Yamamoto, W., Takasaki, H., Hagihara, M., Kuwabara, H., Tanaka, M., Hashimoto, C., Yamazaki, E., Koharazawa, H., Fujimaki, K., Sakai, R., Fujisawa, S., Ishigatsubo, Y. Biweekly THP-COP therapy for newly diagnosed peripheral T-cell lymphoma patients. Hematol Oncol, in press (2014)
|
Oct 29, 2014
|
Yamamoto, W., Nakamura, N., Tomita, N., Takeuchi, K., Ishii, Y., Takahashi, H., Watanabe, R., Takasaki, H., Motomura, S., Kobayashi, S., Yokose, T., Ishigatsubo, Y., Sakai, R. HLA-DR expression on flow cytometry and tumor-associated macrophages in diffuse large B cell lymphoma treated by R-CHOP therapy: Retrospective cohort study. Leuk Lymphoma, in press (2014)
|
Oct 14, 2014
|
Aoyama, A., Katayama, R., Oh-hara, T., Sato, S., Okuno, Y., Fujita, N. Tivantinib (ARQ 197) exhibits antitumor activity by directly interacting
with tubulin and overcomes ABC transporter-mediated drug resistance. Mol Cancer Ther, in press (2014)
|
Oct 07, 2014
|
Alewine, C., Xiang, L., Yamori, T., Niederfellner, G., Bosslet, K., Pastan, I. Efficacy of RG7787, a Next Generation Mesothelin-targeted Immunotoxin, Against Triple-negative Breast and Gastric Cancers. Mol Cancer Ther, in press (2014)
|
Oct 07, 2014
|
Horii, R., Matsuura, M., Dan, S., Ushijima, M., Uehiro, N., Ogiya, A., Honma, N., Ito, Y., Iwase, T., Yamori, T., Akiyama, F. Extensive analysis of signaling pathway molecules in breast cancer: association with clinicoapthological characteristics. Int J Clin Oncol, in press (2014)
|
Oct 07, 2014
|
Kong, D., Yamori, T., Yamazaki, K., Dan, S. In vitro multifaceted activities of a specific group of novel phosphatidylinositol 3-kinase inhibitors on hotspot mutant PIK3CA. Invest New Drugs, in press (2014)
|
Oct 07, 2014
|
Momose, I., Abe, H., Watanabe, T., Ohba, S.I., Yamazaki, K., Dan, S., Yamori, T., Masuda, T., Nomoto, A. Antitumor effects of tyropeptin-boronic acid derivatives: new proteasome inhibitors. Cancer Sci, in press (2014)
|
Sep 18, 2014
|
Katayama, R., Friboulet, L., Koike, S., Lockerman, E.L., Khan, T.M., Gainor, J.F., Iafrate, A.J., Takeuchi, K., Taiji, M., Okuno, Y., Fujita, N., Engelman, J.A., Shaw, A.T. Two novel ALK mutations mediate acquired resistance to the next-generation AKL inhibitor alectinib. Clin Cancer Res, in press (2014)
|
Aug 21, 2014
|
Miyata, K., Takagi, S., Sato, S., Morioka, H., Shiba, K., Minamisawa, T., Takami, M., Fujita, N. Suppression of Aggrus/podoplanin-induced platelet aggregation and pulmonary metastasis by a single-chain antibody variable region fragment. Cancer Med, in press (2014)
|
Jun 26, 2014
|
Mashima, T., Soma-Nagase, T., Migita, T., Kinoshita, R., Iwamoto, A., Yuasa, T., Yonese, J., Ishikawa, Y., Seimiya, H. TRIB1 supports prostate tumorigenesis and tumor-propagating cell survival by regulation of endoplasmic reticulum chaperone expression. Cancer Res., in press (2014)
|
May 07, 2014
|
Nakamura, S., Takahashi, M., Tozaki, M., Nakayama, T., Nomizu, T., Miki, Y., Murakami, Y., Aoki, D., Iwase, T., Nishimura, S., Yamauchi, H., Ohsumi, S., Baba, S., Shimizu, T. Prevalence and differentiation of hereditary breast and ovarian cancers in Japan. Breast Cancer, in press (2013)
|
May 07, 2014
|
Ogura, K., Horii, R., Oosako, T., Iwase, T., Akiyama, F. A clinico-pathological study on cancer in sclerosing adenosis. Breast Cancer, in press (2013)
|
May 07, 2014
|
Horii, R., Akiyama, F. Histological assessment of therapeutic response in breast cancer. Breast Cancer, in press (2013)
|
May 07, 2014
|
Yamamoto, W., Nakamura, N., Tomita, N., Takeuchi, K., Ishii, Y., Takahashi, H., Watanabe, R., Takasaki, H., Motomura, S., Kobayashi, S., Yokose, T., Ishigatsubo, Y., Sakai, R. HLA-DR expression on flow cytometry and tumor-associated macrophages in diffuse large B cell lymphoma treated by R-CHOP therapy: Retrospective cohort study. Leuk Lymphoma, in press (2014)
|
May 07, 2014
|
Tomita, N., Kodama, F., Tsuyama, N., Sakata, S., Takeuchi, K., Ishibashi, D., Koyama, S., Ishii, Y., Yamamoto, W., Takasaki, H., Hagihara, M., Kuwabara, H., Tanaka, M., Hashimoto, C., Yamazaki, E., Koharazawa, H., Fujimaki, K., Sakai, R., Fujisawa, S., Ishigatsubo, Y. Biweekly THP-COP therapy for newly diagnosed peripheral T-cell lymphoma patients. Hematol Oncol, in press (2014)
|
May 07, 2014
|
Osako, T., Iwase, T., Ushijima, M., Horii, R., Fukami, Y., Kimura, K., Matsuura, M., Akiyama, F. Incidence and prediction of invasive disease and nodal metastasis in preoperatively diagnosed ductal carcinoma in situ. Cancer Sci, in press (2014)
|
May 07, 2014
|
Nakano, K., Inagaki, L., Tomomatsu, J., Motoi, N., Gokita, T., Ae, K., Tanizawa, T., Shimoji, T., Matsumoto, S., Takahashi, S. Incidence of pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment. Clin Oncol, in press (2014)
|
May 07, 2014
|
Nakagawa, T., Horii, R., Ito, Y., Iwase, T., Akiyama, F. Development of an easy method to test for HER2 in breast cancer using dual-color in situ hybridization. Breast Cancer, in press (2014)
|
May 07, 2014
|
Lee, S.E., Kang, S.Y., Takeuchi, K., Ko, Y.H. Identification of RANBP2-ALK fusion in ALK positive diffuse large B-cell lymphoma. Hematol Oncol, in press (2014)
|
May 07, 2014
|
Kenmotsu, H., Niho, S., Ito, T., Ishikawa, Y., Noguchi, M., Tada, H., Sekine, I., Watanabe, S.I., Yoshimura, M., Yamamoto, N., Oshita, F., Kubota, K., Nagai, K. A pilot study of adjuvant chemotherapy with irinotecan and cisplatin for completely resected high-grade pulmonary neuroendocrine carcinoma (large cell neuroendocrine carcinoma and small cell lung cancer). Lung Cancer, in press (2014)
|
May 07, 2014
|
Kadota, K., Villena-Vargas, J., Yoshizawa, A., Motoi, N., Sima, C.S., Riely, G.J., Rusch, V.W., Adusumilli, P.S., Travis, W.D. Prognostic significance of adenocarcinoma In situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease. Am J Surg Pathol, in press (2014)
|
May 07, 2014
|
Jin, M., Zhou, Q., Lee, E., Dan, S., Duan, H.Q., Kong, D. AS252424, a PI3Kγ inhibitor, down-regulates inflammatory responsiveness in mouse bone marrow-derived mast cells. Inflammation, in press (2014)
|
Apr 23, 2014
|
Ohishi, T., Muramatsu, Y., Yoshida, H., Seimiya, H. TRF1 ensures the centromeric function of Aurora-B and proper chromosome segregation. Mol Cell Biol, in press (2014)
|
Apr 18, 2014
|
Matsumura, S., Yuge, R., Sato, S., Tomida, A., Ichihashi, T., Irie, H., Iijima, S., Shiba, K., Yudasaka, M.Ultrastructural localization of intravenously injected carbon nanohorns in tumor. Int J Nanomedicine, in press (2014)
|
Apr 11, 2014
|
Sakurai, H., Sugimoto, K.J., Shimada, A., Imai, H., Wakabayashi, M., Sekiguchi, Y., Ota, Y., Izutsu, K., Takeuchi, K., Komatsu, N., Noguchi, M. Primary CNS CCND1/MYC-Positive Double-Hit B-Cell Lymphoma: A Case Report and Review of the Literature. J Clin Oncol, in press (2014)
|
Mar 28, 2014
|
Friboulet, L., Li, N., Katayama, R., Lee, C.C., Gainor, J.F., Crystal, A.S., Michellys, P.Y., Awad, M.M., Yanagiani, N., Kim, S., Pferdekamper, A.C., Li, J., Kasibhatla, S., Sun, F., Sun, X., Hua, S., McNamara, P., Mahmood, S., Lockerman, E.L., Fujita, N., Nishio, M., Harris, J.L., Shaw, A.T., Engelman, J.A. The ALK inhibitor ceritinib overcomes crizotinib resistance in non-small
cell lung cancer. Cancer Discov, in press (2014)
|
Feb 27, 2014
|
Horii, R., Akiyama, F. Histological assessment of therapeutic response in breast cancer. Breast Cancer, in press (2013)
|
Feb 27, 2014
|
Ogura, K., Horii, R., Oosako, T., Iwase, T., Akiyama, F. A clinico-pathological study on cancer in sclerosing adenosis. Breast Cancer, in press (2013)
|
Feb 27, 2014
|
Ono, H., Motoi, N., Nagano, H., Miyauchi, E., Ushijima, M., Matsuura, M., Okumura, S., Nishio, M., Hirose, T., Inase, N., Ishikawa, Y. Long non-coding RNA HOTAIR is relevant to cellular proliferation, invasiveness and clinical relapse in small cell lung cancer. Cancer Med, in press (2013)
|
Feb 25, 2014
|
Lee, S.E., Kang, S.Y., Takeuchi, K., Ko, Y.H. Identification of RANBP2-ALK fusion in ALK positive diffuse large B-cell lymphoma. Hematol Oncol, in press (2014)
|
Feb 25, 2014
|
Tomita, N., Kodama, F., Tsuyama, N., Sakata, S., Takeuchi, K., Ishibashi, D., Koyama, S., Ishii, Y., Yamamoto, W., Takasaki, H., Hagihara, M., Kuwabara, H., Tanaka, M., Hashimoto, C., Yamazaki, E., Koharazawa, H., Fujimaki, K., Sakai, R., Fujisawa, S., Ishigatsubo, Y. Biweekly THP-COP therapy for newly diagnosed peripheral T-cell lymphoma patients. Hematol Oncol, in press (2014)
|
Feb 25, 2014
|
Yamamoto, W., Nakamura, N., Tomita, N., Takeuchi, K., Ishii, Y., Takahashi, H., Watanabe, R., Takasaki, H., Motomura, S., Kobayashi, S., Yokose, T., Ishigatsubo, Y., Sakai, R. HLA-DR expression on flow cytometry and tumor-associated macrophages in diffuse large B cell lymphoma treated by R-CHOP therapy: Retrospective cohort study. Leuk Lymphoma, in press (2014)
|